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In the version of this article originally published online onMay 15, 2014, there was an error in the presentation of the data in Figure 1G.
The colors used to represent myeloid and erythroid colony-forming cells (CFCs) for del(5q) patients were inversed, such that myeloid
CFCs were shown in black and erythoid CFCs in gray. In both the print and online versions of the article, this error has now been
corrected, with the myeloid CFCs being shown in gray and the erythroid CFCs in black.Cancer Cell 25, 861, June 16, 2014 ª2014 Elsevier Inc. 861
